Beta-O2 Technologies For Profit
Beta-O2 technologies is developing the �Air, a Bio-artificial Pancreas (BAP) intended to cure Type 1 diabetes
Technology:
Biomarker panels
Headquarters:
Rosh Ha'ayin, HaMerkaz, Israel
Founded Date:
2004
Last Funding Type:
Venture - Series Unknown
Estimated Revenue:
$4Mper year
Total Funding:
$8.5M
Industry:
Biomarkers of Longevity